Status:
COMPLETED
Intraoperative Ketamine for Patients Undergoing Total Joint Arthroplasty
Lead Sponsor:
Dartmouth-Hitchcock Medical Center
Conditions:
Pain, Postoperative
Arthroplasty Complications
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
Prospective randomized double blinded, placebo controlled study that will evaluate the effect of intra-operative ketamine administration on post-operative analgesic requirements and self-reported pain...
Detailed Description
Pain management can be one of the most challenging aspects of care for total joint arthroplasty patients. Poor post-operative pain control can lead to poor patient satisfaction and functional outcomes...
Eligibility Criteria
Inclusion
- • Adults, 18 years and older, undergoing primary total hip arthroplasty or total knee arthroplasty
Exclusion
- History of intolerance or allergy to ketamine, either documented or self-reported.
- History of increased intra-ocular pressure, uncontrolled hypertension, increased intra-cranial pressure, psychosis.
- Unable to provide consent.
- Current incarceration.
- Pregnant or breast feeding
Key Trial Info
Start Date :
September 14 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04437888
Start Date
September 14 2020
End Date
June 1 2024
Last Update
September 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dartmouth-Hitchcock
Lebanon, New Hampshire, United States, 03766